APA (7th ed.) Citation

N, V., P, A., P, M., S, P., J, V., N, S., . . . P, V. (2020). Prognostic and therapeutic considerations of antibodies against c-ter apolipoprotein A-1 in the general population. Clinical & translational immunology, 9(12), e1220. https://doi.org/10.1002/cti2.1220

Chicago Style (17th ed.) Citation

N, Vuilleumier, et al. "Prognostic and Therapeutic Considerations of Antibodies Against C-ter Apolipoprotein A-1 in the General Population." Clinical & Translational Immunology 9, no. 12 (2020): e1220. https://doi.org/10.1002/cti2.1220.

MLA (9th ed.) Citation

N, Vuilleumier, et al. "Prognostic and Therapeutic Considerations of Antibodies Against C-ter Apolipoprotein A-1 in the General Population." Clinical & Translational Immunology, vol. 9, no. 12, 2020, p. e1220, https://doi.org/10.1002/cti2.1220.